JPRN-UMIN000001903
Completed
Phase 1
Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cells - Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cells
Osaka National Hospital, National Hospital Organization0 sites15 target enrollmentMay 1, 2009
ConditionsMalignant Glioma
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Malignant Glioma
- Sponsor
- Osaka National Hospital, National Hospital Organization
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Pulmonary fibrosis or interstitial pneumonia, or their history, or predisposition to them 2\)Serious drug allergy 3\)Positive for hepatitis B, C, HIV\-1, 2, HTLV\-1 or syphilis 4\)Serious cardiac disease 5\)Active autoimmune diseases 6\)Other cancers 7\)Uncontrollable infection 8\)Pregnancy or lactation 9\)Gelling of plasma, cryogloblinemia 10\)Any reason why, in the opinion of the investigator, the patient should not participate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to investigate safety and efficacy on a combined use of rituximab and auto-gamma/delta T cell therapy for CD20-positive B-cell lymphoma.CD20-positive B-cell lymphomaJPRN-UMIN000003641Japanese Red Cross Medical Center15
Completed
Not Applicable
Clinical study to investigate safety and efficacy on combination of gemcitabine and autologous gamma/delta T cell transfer therapy after resection of pancreatic cancerPancreatic cancerJPRN-UMIN000000931The University of Tokyo Hospital30
Active, not recruiting
Phase 3
A Clinical Study to Evaluate the Safety and Efficacy of Livercure Tablets on Patients with Liver Cirrhosis.Health Condition 1: K745- Biliary cirrhosis, unspecifiedHealth Condition 2: K745- Biliary cirrhosis, unspecifiedCTRI/2022/07/043725Jammi Pharmaceuticals Pvt Ltd
Completed
Phase 2
Clinical study to evaluate the safety and efficacy of cinnamon in the management of non-alcoholic fatty liver diseaseHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedCTRI/2021/03/032039Central council for research in Unani medicine New dehli60
Completed
Not Applicable
To study the effect of Tab HFO-O2 in fatty individuals.CTRI/2016/07/007067Baidyanath Bhavan Pvt Ltd